EAU 2017 - Bladder Cancer

Viewing 1-20 of 23 articles

EAU 2017: Perioperative chemotherapy does not improve disease free survival in upper tract urothelial carcinoma: a population based analysis

EAU 2017: State-of-the-art Lecture: How will Immunotherapy Change the Treatment Paradigm?

EAU 2017: State-of-the-art Lecture: Is There Still a Role for Chemotherapy?

EAU 2017: Updated meta-analysis (MA) of salvage therapy for metastatic urothelial cancer (mUC): Comparing outcomes of immunotherapy (IT) vs. single agent and doublet chemotherapy (CT)

EAU 2017: State of the Art Lecture: Enhanced Recovery After Surgery (ERAS) for Bladder Cancer: Non-Surgical Options to Improve Outcomes of Cystectomy

EAU 2017: State of the Art Debate - Evidence for extent of lymphadenectomy in urothelial bladder cancer

EAU 2017: Debate - Do we need to follow-up in low grade bladder tumor after 12 months?-Yes (EAU Guidelines)

EAU 2017: Perfect adjuvant treatment

EAU 2017: Perfect transurethral resection

EAU 2017: Pure histological variants are associated with poor survival at radical cystectomy in patients with bladder cancer

EAU 2017: Efficacy of long acting sandostatin on reducing mucus production in patients with ileal neobladder

EAU 2017: Increasing use of incontinent urinary diversion: A total population analysis of radical cystectomies in Germany from 2006 to 2013

EAU 2017: The use of antibiotic prophylaxis in patients undergoing radical cystectomy for bladder cancer

EAU 2017: 20-gene expression signature to predict lymph node positive disease at radical cystectomy for muscle-invasive bladder cancer: Not validated

EAU 2017: IMvigor010, a phase III study of adjuvant atezolizumab vs observation in patients (pts) with muscle-invasive urothelial carcinoma (UC)

EAU 2017: PURE01: An open label, single-arm, phase 2 study of the anti-programmed death (PD)-1 monoclonal antibody (moAb) pembrolizumab for neoadjuvant therapy of muscle-invasive urothelial bladder carcinoma (miUBC)

EAU 2017: Comparison effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder

EAU 2017: Can radical cystectomy be performed safely in the metastatic setting? Location of metastatic bladder cancer as a determinant of in-hospital mortality

EAU 2017: Debate on bladder cancer surgery: open cystectomy is still the way - Con

EAU 2017: Multimodal bladder preservation technique for muscle invasive bladder cancer: Results from a prospective trial

1
2

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.